The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: Namibia's weak domestic manufacturing capabilities and strong colonial ties with South Africa
will ensure the country continues to import the majority of its pharmaceutical needs over the coming years.
Despite a relatively attractive business environment, multinational drugmakers will continue to use South
Africa as the main channel trough which medicines are imported into the country, and will be unlikely to
establish a direct manufacturing presence. Local production of antiretroviral medicines will give a small
boost to the country's limited export potential.
Headline Expenditure Forecasts
- Pharmaceuticals: NAD2.34bn (USD183mn) in 2015 to NAD2.54bn (USD165mn) in 2016; +8.6% in
local currency and -10.0% in US dollar terms. Forecast virtually unchanged from last quarter.
- Healthcare: NAD14.3bn (USD1.12bn) in 2015 to NAD15.7bn (USD1.0bn) in 2016; +9.8% in local
currency and -9.0% in US dollar terms. Forecast in US dollar terms revised slightly upwards from last